Clinical trial · Observational
Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous Neoplasia
Diagnostic Value of Virtual Chromoendoscopy With Optical Enhancement Technology in Early Esophageal Squamous Neoplasia: A Prospective Comparative Study
NCT02851264CI-TRIAL-00023306unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aims of the present study: 1. To investigate the diagnosing value of optical enhancement technology for early esophageal squamous neoplasia. 2. To assess the detection rate of early esophageal squamous neoplasia by virtual chromoendoscopy with optical enhancement technology .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Early Esophageal Squamous Neoplasia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Optical enhancement technology examination
- description
- After routine examination by white-light endoscopy,the imaging mode will be switched to optical enhancement.Suspicious area will be recorded in detail. Then all enrolled patients will have their esophagus sprayed with iodine solution. Suspicious area will be also recorded in detail.After that biopsy specimens will be obtained respectively by forceps from each suspicious lesion recorded for histologic diagnosis.
Primary outcomes (1)
- measure
- The detection rate of early esophageal squamous neoplasia by optical enhancement technology.
- timeFrame
- 12 months
- description
- The detection rate of early esophageal squamous neoplasia by using optical enhancement and Lugol chromoendoscopy.
Secondary outcomes (3)
- measure
- The diagnostic accuracy of optical enhancement technology on early esophageal squamous neoplasia.
- timeFrame
- 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with high-risk factors for esophageal squamous cell carcinoma who meet any of follows: * Long term living in the high incidence area of esophageal squamous cell carcinoma ; * First degree relatives have a history of esophageal squamous cell carcinoma ; * Previous history of esophageal lesions ( esophageal squamous neoplasia ); * The patients having a history of cancer; * A long history of smoking ; * A long history of drinking ; * Having bad eating habits such as eating fast, hot diet, high salt diet, eating pickles. 2. Patients aged between 40 to 74 years old. Exclusion Criteria: 1. Having advanced esophageal carcinoma; 2. After esophageal surgery or endoscopic treatment ; 3. Known esophageal radiotherapy or chemotherapy ; 4. Esophageal stenosis; 5. Acute bleeding; 6. A known allergy to iodine; 7. Coagulopathy (prothrombin time \<50% of control, partial thromboplastin time \>50 seconds); 8. Having food retention; 9. Severe hepatic ,renal, cardiovascular or metabolic dysfunction ; 10. Being pregnant or lactating;
References
Publications (0)
Data not yet available
No reference posted for this study.